Gentarget Lentivirus

Innova Shaker S44i inc

SHA3066 EACH
EUR 18331.41

Gentarget Inc. Laboratories manufactures the gentarget lentivirus reagents distributed by Genprice. The Gentarget Lentivirus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact GenTarget Inc.. Other Gentarget products are available in stock. Specificity: Gentarget Category: Lentivirus

True Blue

5mg Ask for price
  • SMILES: N=C(C1=CC=C(OC(/C=C/C2=CC3=CC(C(N)=N)=CC=C3O2)=C4)C4=C1)N.Cl.Cl
  • Formula: C20H18Cl2N4O2
Description: True Blue

Innova Shaker S44i inc

EACH
EUR 18331.41

JBS True Blue

300µl
EUR 13.7

JBS True Blue

300 µl
EUR 16
Description: JBS True Blue

True Blue Chloride

100mg
EUR 11200
  • C₂₀H₁₆N₄O₂ • 2HCl
Description: 71431-30-6

Innova Shaker S44i inc - EACH

EACH
EUR 26698.95

Lentivirus and Retrovirus Purification Kit

100 Preps
EUR 1244.4

Biology information

dCas9-RFP Lentivirus

LVP1593 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-RFP fusion, does not contain any antibiotic selection.

m Tnfrsf10b Lentivirus

LVP1414 1x10^7 IFU/ml x 200ul
EUR 276.5
Description: Over-expression lentivirus for mouse target: Tnfrsf10b, containing a RFP-Blasticidin dual selection marker.

dCas9-KRAB Lentivirus

LVP1549 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-KRAB fusion, containing no selection

dCas9-HSF1 Lentivirus

LVP1581 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-HSF1 fusion, does not contain any antibiotic selection.

dCas9-GAL4 Lentivirus

LVP1585 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-GAL4 fusion, does not contain any antibiotic selection.

dCas9-Null Lentivirus

LVP1597 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made control lentivirus express dCas9-Null fusion, do not contain any antibiotic selection.

dCas9-DNMT1 Lentivirus

LVP1561 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-DNMT1 fusion, containing no antibioic selection.

EF1a control lentivirus (No Selection) EF1a control lentivirus (No Selection)

EF1a-Null- 1 x10^7 IFU/ml x 200ul
EUR 206.5
Description: Negative control lentivirus under EF1a promoter, does not contain any antibiotic selection.

dCas9-DNMT3a Lentivirus

LVP1553 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-DNMT3a fusion, containing no antibioic selection.

dCas9-DNMT3b Lentivirus

LVP1557 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-DNMT3b fusion, containing no antibioic selection.

dCase-APOBEC Lentivirus

LVP1565 1x10^8 IFU/ml x 200ul
EUR 553
Description: Pre-made lentivirus express dCas9-APOBEC fusion, containing no any antibiotic selection.

h HLA-C Lentivirus

LVP1417 1x10^7 IFU/ml x 200ul
EUR 276.5
Description: Over-expression lentivirus for human target: HLA-C, containing a RFP-Blasticidin dual selection marker.

CRE (Neo), CMV lentivirus

LVP297 1x107 IFU/ml x 200ul
EUR 418.8
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker, provided in DMEM medium with 10% FBS.

CRE (Bsd), CMV lentivirus

LVP336 1x107 IFU/ml x 200ul
EUR 418.8
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker, provided in DMEM medium with 10% FBS.

CRE (Bsd), CAG lentivirus

LVP574 1x107 IFU/ml x 200ul
EUR 418.8
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Blasticidin marker, provided in DMEM medium with 10% FBS.

CRE (Neo), CAG lentivirus

LVP575 1x107 IFU/ml x 200ul
EUR 418.8
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Neomycin marker, provided in DMEM medium with 10% FBS.

CRE (Puro), CMV lentivirus

LVP339 1x107 IFU/ml x 200ul
EUR 418.8
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Puromycin marker, provided in DMEM medium with 10% FBS.